Dynavax Technologies





Ebitda 변화 날짜
AbbVie USD 3.52B 828M 2025-09
Adma Biologics USD 58.74M 14.75M 2025-09
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Biogen USD 573.2M 253.7M 2025-12
BioMarin Pharmaceutical USD 295.45M 49.49M 2025-06
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Dynavax Technologies USD 35.53M 10.9M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 246.7M 93.8M 2025-09
Novartis USD 5.88B 290M 2025-09
Pfizer USD 6.08B 351M 2025-09
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD 126.42M 416.82M 2025-06
TG Therapeutics USD 37.7M 25.41M 2025-06
Vertex Pharmaceuticals USD 1.44B 100.4M 2025-09


Dynavax Technologies - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.